New protein kinase C activator regulates amyloid precursor protein processing in vitro by increasing α‐secretase activity
Authors:
- 23 July 2007
- journal article
- Published by Wiley in European Journal of Neuroscience
- Vol. 26 (2) , 381-391
Abstract
The beta amyloid (Aβ) cascade has been at the forefront of the hypothesis used to describe the pathogenesis of Alzheimer's disease (AD). It is generally accepted that drugs that can regulate the processing of the amyloid precursor protein (APP) toward the non‐amyloidogenic pathway may have a therapeutic potential. Previous studies have shown that protein kinase C (PKC) hypofunction has an important role in AD pathophysiology. Therefore, the effects of a new PKC activator, α‐APP modulator [(2S,5S)‐(E,E)‐8‐(5‐(4‐(trifluoromethyl)phenyl)‐2,4‐pentadienoylamino)benzolactam (TPPB)], on APP processing were investigated. Using PC12 cells and SH‐SY5YAPP695 cells, it was found that TPPB promoted the secretion of sAPPα without affecting full‐length expression of APP. The increase in sAPPα by TPPB was blocked by inhibitors of PKC, extracellular signal‐regulated kinase (ERK), c‐Jun N‐terminal kinase (JNK) and tyrosine kinase, suggesting the involvement of these signal transduction pathways. TPPB increased α‐secretase activity [a disintegrin and metalloproteinase (ADAM)10 and 17], as shown by direct fluorescence activity detection and Western blot analysis. TPPB‐induced sAPPα release was blocked by the metalloproteinase inhibitor TAPI‐2, furin inhibitor CMK and by the protein‐trafficking inhibitor brefeldin. The results also showed that TPPB decreased β‐secretase activity, Aβ40 release and beta site APP‐cleaving enzyme 1 (BACE1) expression, but did not significantly affect neprilysin (NEP) and insulin‐degrading enzyme (IDE) expression. Our data indicate that TPPB could direct APP processing towards the non‐amyloidogenic pathway by increasing α‐secretase activity, and suggest its therapeutic potential in AD.Keywords
This publication has 53 references indexed in Scilit:
- MARCKS is a major PKC-dependent regulator of calmodulin targeting in smooth muscleJournal of Cell Science, 2005
- Alzheimer’s disease: Channeling APP to non-amyloidogenic processingBiochemical and Biophysical Research Communications, 2005
- Differential involvement of protein kinase C alpha and epsilon in the regulated secretion of soluble amyloid precursor proteinEuropean Journal of Biochemistry, 2004
- Amyloid beta peptide directly inhibits PKC activationMolecular and Cellular Neuroscience, 2004
- Stimulation of β-amyloid precursor protein α-processing by phorbol ester involves calcium and calpain activationBiochemical and Biophysical Research Communications, 2004
- Role of protein kinase Cα in the regulated secretion of the amyloid precursor proteinMolecular Psychiatry, 2003
- A secreted form of human ADAM9 has an α-secretase activity for APPBiochemical and Biophysical Research Communications, 2002
- Blockade of PKCϵ Activation Attenuates Phorbol Ester-Induced Increase of α-Secretase-Derived Secreted Form of Amyloid Precursor ProteinBiochemical and Biophysical Research Communications, 2001
- Constitutive overactivation of protein kinase C in guinea pig brain increases α‐secretory APP processing without decreasing β‐amyloid generationEuropean Journal of Neuroscience, 2000
- Specific role for protein kinase Cα in the constitutive and regulated secretion of amyloid precursor protein in human skin fibroblastsNeuroscience Letters, 1998